Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

NCT03673943 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Radiomedix, Inc.